A study conducted on a lipid vaccine (lipo-saponins/bFGF) with Astragalus saponin adjuvants and a recombinant human basic fibroblast growth factor (bFGF) protein antigen reported significant anticancer effects in a CT26 lung cancer metastasis model. Here, FGF2 is linked to lung carcinoma.